Pericellular proteolysis involves the plasminogen activatorlplasmin system and plays an important role in cell remodeling involving cell migration and extracellular materized a model of proliferative glomerulonephritis induced by Habu snake venom (HSV) in the rat that involves cell migration, pml&eration, and extracellular matrix accumulation. Because-plasminogen activator-inhibitor-1 (PAI-1) has been used as a marker for cell migration as well as matrix accumulation, we wexe interested in examhing the temporal and spatial expression and cellular sources of PAI-1 mRNA and translated protein Over the course of HSV-induced prolifesative glomerulonephritis. The results showed a highly localized and progressive expression of PAI-1 mRNA and translated protein by in situ hybridization and immunohistochemistry at the margins and periphery of glomerular lesions 8 and 24 hr after HSV. The expression of PAI-1 in aixtumover. studiesinthislaboratoryhavepreviodycharac-Supported by grants from the National Institutes of Health (NIDDK, DK38758) and the Office Curl Dr., San Antonio, TX 78284. glomerular lesions localized to the same sites as mesangial cell marker proteins, desmin and Thy-1.1, indicating that mesangial &lls synthesize this important regulator proteolysis. Few cells expressed PAL1 in the central aspects of glomerular lesions at later time intervals (48 and 72 hr) when cell proliferation and expression of extracellular matrix (fibroneain protein and "A)
Introduction
Control of extracellular proteolysis is an important event in tissue remodeling during embryogenesis and in disease situations including angiogenesis, atherosclerosis, wound healing, and tumorigenesis (1-9). Tissue remodeling usually involves a cycle of events starting with loss of cell adhesion from its extracellular matrix (ECM) substratum, cell migration towards sites of tissue injury or inflammation, prolikration, dfirentiation, and reorganization involving synthesis of ECM (2). Different enzyme cascades, such as the plasminlplasminogen system and several metalloproteinases, including stromelysin, collagenase, and gelatinase, cooperate in degra-dation of a variety of ECM proteins and are instrumental in turnover of extracellular matrix during tissue remodeling (1, 4, 5, 7, 10) .
A prerequisite for cell migration is pericellular proteolysis required to release adhesive contact from ECM and remove proteinaceous barriers to cell motility (9) . The plasminogen activator/ plasmin system is central to ECM proteolysis (6-9). This system involves two distinct activators of plasminogen: urokinase (U) plasminogen activator (PA) and tissue (t) PA. PAS convert plasminogen to plasmin, a potent serine protease capable of degrading most ECM proteins (6-9). In addition, plasmin activates metalloproteinase precursors and might play a pivotal role in matrix tumover (4-10). uPA is secreted as a pro-uPA, which rapidly binds to a uPA surface receptor where it is available for interaction with plasminogen, which is readily available in plasma and interstitial compartments (11) (12) (13) . uPA and tPA are both inactivated by plasminogen activator-inhibitor-1 (PAI-I). Therefore, cell migration and ECM accumulation are believed to be controlled by PAI-1 (14-16). Paradoxically, PAI-1 is often expressed concurrently with uPA or tPA, and therefore has been used as a histochemical marker for cell migration or active remodeling (17-21). On the other hand, PAL1 expression has been used as an indicator for ECM accumulation in chronic disease at a point when uPA 9r tPA expression decreases (22, 23) .
Glomerular mesangial cells synthesize and release uPA, tPA, and PAL1 in vitro (24) (25) (26) (27) and may utilize this system to regulate cell migration or ECM accumulation during remodeling in glomerular disease (23.27). Mesangial cells migrate in vitro in response to denudation injury (28) and in response to platelet secretory products (29, 30) . We have also shown a redistribution of mesangial cells from intact capillary tufts to peripheral aspects of early glomerular lesions in Habu snake venom (HSV)-induced proliferative glomerulonephritis, suggesting that these cells migrate in vivo during tissue remodeling (31) . This model is characterized by early mesangiolysis, bdmning of capillaries, and formation of microaneurysms filled with platelet aggregates, leukocytes, and blood proteins. The lesions eventually fill with mesangial cells (identified by the phenotypic marker proteins desmin and Thy-l), forming micronodules consisting of masses of cells (31) (32) (33) . Mesangial cells are believed to migrate from intact glomerular capillary tufts towards the microaneurysms and might be an important event in the repopulation of glomerular lesions. Development of advanced lesions in this model is also associated with mesangial cell synthesis of ECM proteins, including collagen and cellular fibronectin (32, 33) . Because the plasminogenlplasmin system is involved in both cell migration and matrix accumulation, we were interested in examining the temporal expression and cellular sources of PAL1 during the course of HSV-induced glomerulonephritis.
Materials and Methods

Induction of Glomerulonephritis
Glomerular lesions were induced in male Sprague-Dawley rats (Charles River; Wilmington, MA) weighing 200-250 g as previously reported (31) (32) (33) .
Experiments were conducted under the Public Health Service policies on humane care and use of laboratory animals. Briefly, the rats were unilaterally nephrectomized to increase the incidence of glomerular lesions, and 24 hr later were injected with HSV (Trimererrtnrsflavoviridir; Sigma, St Louis, MO) at a dose of 3 mg/kg IV. At 8 (n = 4). 24 (n = 4), 48 (n = 4). or 72 (n = 4) hr after injection of HSV. the rats were sacrificed and slices of renal cortex were obtained and immersed in 10% neutral buffered formalin for subsequent processing, paraffin embedding, and light microscopic evaluation. Additional slices of cortex were snap-frozen in liquid niuogen for subsequent immunodetection of cell phenotypic markers and PAI-1 within glomerular lesions. Separate frozen slices of renal cortex were obtained for in situ hybridization.
Immunoiocaiization of PAI-1
Glomerular localization of PAI-1 was assessed with a rabbit polyclonal antibody specific for rat PAI-1 (American Diagnostica; Greenwich, CT). Frozen sections were incubated for 30 min each with anti-PAL1 antibody (20 pglml), biotinylated rat anti-rabbit IgG (Zymed Laboratories; South San Francisco, CA) as second antibody, then by RTC-labled avidin D (Vector Laboratories; Burlingame. CA) with 10-min washes with 0.02 M PBS, pH 7.4, between each step. Controls consisted of rabbit IgG or PBS in place of primary antibody. The sections were coverslipped and examined and photographed with an Olympus research microscope (Olympus Instruments; Dallas, TX) equipped with epifluorescence. Expression of PAI-1 was quantitated by recording the number of glomerular lesions and the location of PAI-1 expression in an average of 100 glomerular lesions per time period (see Table 1 ). Location of staining was defined as: (a) interface, the margin of the lesion between the intact glomerular tuft and lesion; (b) peripheral, the margins of lesions around the entire periphery of the lesion including the interface; (c) central, the central aspects of glomerular lesions; or (d) parietal epithelium, staining in the epithelium lining Bowman's capsule.
Characterization of Cell Types Within Glomerular Lesions
HSV-induced glomerular lesions involve a temporal and spatial course of cell infiltration during the development of proliferative lesions. The lesions are characterized first by microaneurysms filled with platelet aggregates and infiltrating neutrophils and macrophages. These cells diminish over time as resident glomerular mesangial cells W1 the lesions. forming micronodules (31) (32) (33) . Cell types within glomerular lesions were identified by immunoperoxidase or immunofluorescence histochemistry using phenotypic markers as previously described (31) (32) (33) : for mesangial cells, mouse monoclonal anti-desmin (Dako; Santa Barbara, CA) and mouse monoclonal anti-rat Thy 1.1. clone OX 7 (Accurate Chemical and Scientific; Westbury, NY); for monocytes and macrophages, mouse monoclonal anti-rat myeloid cell, done ED-1 (Bioproducts for Science; Indianapolis, IN). Biotinlabeled secondary antibody was monoclonal rat anti-mouse IgG (Zymed).
Controls consisted of ascites containing non-immune IgG of the appropriate IgG isotype of primary antibody or diluent as above. Acetone fixed frozen sections were treated in a similar fashion as previously described (31) (32) (33) .
Macrophages were also identified and verified in glomerular lesions by in situ hybridization for the expression of lysozyme mRNA, a marker for macrophages during wound healing (34) and used previously to identify macrophages in glomerular lesions in the HSV model (33; see above). Staining at the interface and periphery of lesions at 24 hr was linear. Moa lesions at 72 hr were micronodules and did not stain for PAI-1.
Dual Labeling for PAI-1 and Mesangial Cells
Because our results showed an early localization of PAI-1 protein in the margins of early glomerular lesions at sites occupied by mesangial cells (primarily at 24 hr after HSV; see Results), dual labeling experiments were performed at this time to verify co-localization of PAI-1 antigen with mesangial cells (Thy-1 antigen) in the same section. These experiments were performed by consecutively incubating sections with rabbit anti-PAL1 and mouse anti-Thy1 for 30 min each with three 10-min PBS washes in between. After additional PBS washes, second antibodies, rhodamine-conjugated goat antirabbit IgG and FIX-labeled monoclonal rat anti-mouse IgG, were each applied separately for 30 min each, with three lo-min washes in between. Before use. rhodamine-conjugated goat anti-rabbit IgG was absorbed with rat platelet-poor plasma and mouse serum to block crossreactivity to rodent IgG. Similarly, the monoclonal rat anti-mouse IgG does not recog nize rat IgG and was adsorbed with rabbit IgG to block crossreactivity to the rhodamine-labeled rabbit secondary antibody. Absence of crossreactivity of the adsorbed second antibody with non-target primary antibody (i.e., FITC-rat anti-mouse IgG vs rabbit anti-PAM or rhodamine anti-rabbit IgG vs mouse anti-Thy-1) was verified in control sections incubated with each primary antibody alone, followed by the adsorbed second antibody.
In Situ Hybridzation
Plasmid DNA. PAI-1 cDNA was generously provided by Dr. Thomas Gelehrter. University of Michigan (35) . A 528 BP Sac I fragment of rat PAI-1 cDNA corresponding to bases 432-960 ofthe GenBank database (M24067) was subcloned into pGEM-3Zf+ plasmid (Promega; Madison, WI) and used for generation of labeled riboprobes to detect cellular localization of rat PAI-1 transcript within glomerular lesions. A 438 BP PCR generated cDNA fragment in pGEM-3 representing murine lysozyme (GenBank J03846) generously provided by L. Van De Water, Harvard University; 34) was used to synthesize riboprobes for in situ phenotypic identification and verification of macrophages within lesions. AI1 experiments were performed simultaneously with labeled sense riboprobe (anti-complementary to "A) as a negative control.
Preparation of Ribopmbes. Linearized cDNA was transcribed in vitro using a Riboprobe system I1 kit (Promega) according to the manufacturer's instructions. Either SP6 or T7 RNA polymerase and [35S]-uridine-5'-(athio)-triphosphate (1300 Cilmmol; New England Nuclear. Boston, MA) was included in the reaction mixture to generate 35S-labeled anti-sense and sense riboprobes. The reaction mixture was incubated for 60 min at 40'C and then the DNA template removed by digestion with 0.5 U RNAse-free DNAse, followed by removal of unincorporated nucleotides by phenollchloroform extraction and ethanol precipitation. RNA probes (specific activity approximately 4 x lo6 CPMlpl) were stored at -7O'C and used within 3 days. Tissue Preparation. Frozen sections (6 pm) were cut and collected on aminosilanelglutaraldehyde-treated slides, then fixed for 20 min in 4% paraformaldehyde in 0.01 M PBS, pH 7.4. The sections were washed twice in PBS, dehydrated through a graded series of ethanols, air-dried, and immediately used for in situ hybridization.
Tissue Hybridization. In situ hybridization procedures involving prehybridization. hybridization, and removal of nonspecifically bound probe were performed as previously described (33) . Pre-hybridization steps included treatment with 0.2 N HCI, proteinase K (1 pglml), and acetic anhydride to block background and enhance probe penetration. Twenty-five p1 of hybridization mixture containing 50% formamide, 10% dextran sulfate, 10 mM dithiothreitol, 0.1 M %is-HC1, pH 7.5, 0.1 M NaP04, 0.3 M NaCI, 50 mM EDTA. 1 x Denhardt's solution, 0.2 mglml yeast tRNA, and 2 x 10' CPM of 35S-labeled riboprobe was applied to each section and covered with a siliconized coverslip. Hybridizations were performed in a sealed humid chamber for 18 hr at 50'C. Excess probe w1s removed by washing in TE b&r treated with R N k A to decrease nonspecific background activity and rinsed in 2 x standard saline citrate (SSC). Sections were dehydrated in graded ethanols, air-dried, and immersed, in the dark, in Kodak NTB-2 photographic emulsion (Eastman-Kodak; Rochester, NY).
After air-drying the sections were kept at 4% and exposed for 2-3 weeks. The emulsion was developed and stained with hematoxylin and eosin for subsequent light microscopic analysis. The number and location of cells expressing PAI-1 mRNA were quantitated in a similar fashion as described for immunolocalization of protein, except that positive cells were defiied as cells with at least five grains in the overlying autoradiographic emulsion. The number of positive cells was counted at (a) the interface between the intact glomerular tuft and lesion. (b) the margins around the periphery of lesions, excluding the interface, (c) the central aspects of glomerular lesions (microaneurysms and micronodules), and (d) the parietal epithelium lining Bowman's capsule.
Erpression of ECM
Expression of cellular fibronectin (Fn) was used as a marker for ECM synthesis as previously described (33) . Tissue was prepared for immunohistochemistry and in situ hybridization as outlined above. Glomerular localization of Fn was assessed with a mouse monoclonal antibody against cellular Fn (clone FN-3E2; Sigma). The antibody is specific for cellular Fn and does not crossreact with plasma Fn (33) . Immunofluorescence localization of Fn was examined in frozen sections as described above, using an anti-cellular Fn antibody and FIX-labeled rat anti-mouse IgM (Zymed) as second antibody. Controls consisted of mouse IgM ascites or PBS in place of primary antibody, as outlined above.
For in situ hybridization, a 270 BP segment of Fn cDNA (na 1830-2100, L00191) subcloned into pGEM-2 plasmid (generously provided by Richard 0. Hynes, Massachusetts Institute of Technology) was used for generation of labeled riboprobes to detect cellular localization ofFn transcript within glomerular lesions (33) . The anti-sense traoScript (complementary to "A) corresponds to a region (C) in the Type 1 repeats near the COOH terminal end of Fn common to all known forms of Fn mRNA (36) . Tissue sections were hybridized as above utilizing "Mabeled RNA in the anti-sense and sense orientations.
Results
Mol-pbology
HSV induced a proliferative glomerulonephritis as described previously (31) (32) (33) 37) . The lesions were characterized by mesangiolysis and capillary ballooning, resulting in microaneurysms filled with platelet aggregates, leukocytes, erythrocytes, and plasma proteins at 8 and 24 hr (Figure la). By 48 hr after HSV, most lesions were filled with many ovoid and round cells. Lesions at 72 hr after HSV were characterized by formation of micronodules composed of a confluent cellular mass ( Figure Ib) .
Expression of PAI-1 Protein Seen by Immunofluorescence Histocbemktry
Our studies are in agreement with those of Tomooka HSV was predominantly localized in a focal pattern at the intact glomerular capillary tuft-lesion interface, with little or no staining at the peripheral aspects of glomerular lesions (Figure 2a ). Most lesions at 8 hr were devoid of PAL1 staining (Table 1) . Staining for PAL1 at 24 hr after HSV was more intense and extensive, involving almost all glomeruli and showing PAI-1 staining along the margins of lesions at the glomerular tuft-lesion interface or including the peripheral aspects of microaneurysms (Figure 2b) . The distribution of staining at the margins and periphery of lesions paralleled staining described for desmin and Thy-1.1 (see below).
At 48 hr after HSV, staining for PAI-1 decreased in intensity and was observed diffusely throughout the lesion (Figure 2c ). Cells at the marginal aspects of glomerular lesions tended to stain more intensely than cells located within the central aspects of lesions (Fig-ure 2c) . By 72 hr after HSV, staining for PAL1 diminished and was absent in most micronodular lesions ( Figure Id) ; however, isolated cells in occasional glomerular lesions demonstrated PA14 staining. Parietal epithelial cells lining Bowman's capsule stained for PAI-1 in many glomerular lesions at 24.48, and 72 hr after HSV ( Figures  2c and 2d ; Table 1 ).
Cell Qpes Within Glomerular Lesions
Cell infiltration within HSV-induced glomerular lesions followed the same pattern as previously described (31) (32) (33) . Mesangial cells, identified by phenotypic staining with desmin and Thy-1.1 antibody, became apparent at 8 hr after HSV, focally at the interface between lesions and intact capillary tufts. However, mesangial cells were absent from the interface of most lesions (31) . Glomeruli at 24 hr after HSV showed desmin-and Thy-1-positive mesangial cells at the interface and/or along the entire periphery of nearly all lesions (Figure 2e ). Desmin-and Thy-1-positive mesangial cells were not observed in the central aspects of microaneurysms at 8 and 24 hr after HSV. However, advanced lesions at 48 hr after HSV showed many mesangial cells within the central aspects of microaneurysms (not shown). By 72 hours after HSV, the lesions were composed primarily of desmin-or Thy-1-staining cells (Figure 2f ), corresponding to identification of mesangial cells as the primary cell type in micronodules as previously described (31) (32) (33) 37) . Lesions were devoid of other resident glomerular epithelial and endothelial cells, based on the absence of phenotypic markers for these cell types within lesions.
Macrophages, identified by ED4 staining by immunohistochemistry and expression of lysozyme mRNA by in situ hybridization (Figure 3) , were identified within central aspects of glomerular lesions, first becoming apparent at 8 hr after HSV and then increasing in number until they peaked at 48 hr after HSV. The macrophages were observed almost exclusively within the central aspects of microaneurysms ( Figure 3a ) and occasionally at the periphery of lesions, including the glomerular tuft-lesion interface. In advanced lesions at 72 hr after HSV. macrophages within lesions declined ( Figure 3b ). As reported previously, counts of ED-1-positive cells in glomerular lesions revealed an average of 0.68 -e 0.1 (SEM),
2.5 f 0.3, 3.7 f 0.3. and 1.9 2 0.1 at 8. 24, 48, and 72 hr after HSV. respectively (33) .
Co-localization of PAI-1 ana' Mesangial Cells by Dual Labeling
Dual labeling immunofluorescence microscopy utilizing antibodies to PA14 and Thy-1 showed co-localization of PAL1 protein with this phenotypic marker of mesangial cells (Figure 4) , confirming that the primary source for PAL1 at the margins of lesions was maangial in origin. In addition, cells in Bowman's capsule (parietal epithelial cells) stained for PAL1 but were Thy-1-negative ( Figure 4 ).
Expression of PAI-1 m R N A by in Situ Hybridization
Expression of PAL1 mRNA was undetectable in structures in the cortex in normal, untreated rat kidneys. Cellular expression of PAL1 (1) Mesangial cells within the micronodule (arrows) stain for Thy-1. Bar = 50 urn. t mRNA was consistent with immunodetection of PAI-1 protein and was observed in highly localized areas within glomerular lesions over the course of HSV-induced glomerular injury ( Figure 5 ; Table  2 ). Expression of PAI-1 mRNA was first observed within glomerular lesions at 8 hr after HSV, when the message was observed focally in cells at the interface between the intact glomerular capillary tuft and the microaneurysm (Figure >a) , but a few positive cells were observed in peripheral or central aspects of microaneurysm in a minority of affected glomeruli at this time ( Table 2) . As with PAI-1 protein, many glomeruli were devoid of message. By 24 hr after HSV, however, cells expressing PAI-I mRNA were more frequent and intense, localizing in many cells at the tuft-lesion interface and along the peripheral aspects of microaneurysms of the majority of glomeruli (Figure 5b ). Cellular expression for PAI-1 mRNA was infrequently observed in central aspects of glomerular lesions at 8 and 24 hr after HSV (Figures 5a and 5b) . By 48 hr after HSV, the number of cells expressing PAI-1 mRNA w i d h the ccn-U?l aspects of lesions increased. but tended to remain near the glomerulus-ksion interface. By 72 ht after HSV, accnsiOna isoperiphery ofmimnodules, showed PAM lesions did not express PAM mRNA ( F i i Most early lesions (8 hr) were devoid of cells expressing Fn mRNA by in situ hybridization. However, occasional cells within the central aspects of microaneurysms showed signal at this time. These cells were identified as mononuclear cells or macrophages (as above) on the basis of the temporal location of macrophage markers (ED-1 antigen and lysozyme "A) and the absence of resident glomerular cells in this region at this time. Expression of Fn transcript increased at 24 hr after HSV (Figure 6c) and was associated with the increase in the number of macrophages within lesions. A few cells at the margins of lesions also expressed Fn message above that observed in the mesangium in intact glomerular capillary tufts. At 48 and 72 hr after HSV, the number of mesangial cells within lesions increased, as did the expression of Fn mRNA, correlating with the increase in translated protein detected by immunoperoxidase histochemistry. Maximal expression of Fn mRNA (Figure 6d ) and protein was detected 72 hr after HSV.
Discussion
These studies show expression of PAL1 mRNA and translated protein in a highly localized pattern within diseased glomeruli after treatment with HSV. PAL1 mRNA and translated protein were observed in focal cells at the lesion-glomerulus interfacc at 8 hr, increasing in intensity and cell numbers by 24 hr after HSV. The cxpression of PA14 in the margins of lesions paralleled the expression Table 2 of phenotypic markers for mesangial cell determinants (desmin and Thy-1.1). indicating that mesangial cells express PAL1 mRNA and translated protein in a disease situation. PA14 protein and mRNA signal were rarely observed in cells within the central aspects of glomerular lesions at these times. The cells in central aspects of microaneurysms have been shown in this and previous studies to be macrophages, based on the cellular expression of the markers of this cell type (lysozyme mRNA and ED-1 surface antigen) and absence of mesangial cell markers in this location at these times. Neutrophils, identified by their characteristic nuclear morphology, did not express PAI-1. Cellular expression of PAI-1 mRNA and protein diminished at later time intervals, 48 and 72 hr after HSV, but often remained elevated in cells adjacent to the glomeruluslesion interface and in epithelial cells lining Bowman's capsule. PAI-1 has been implicated in renal disease as a mediator of ECM accumulation (23) and as a feedback mechanism to limit vascular fibrinolysis (38-42). Mesangial cells in culture also express components of the plasminogenlplasmin system including uPA. tPA, and uPA receptor @PAR), and PA14 (24-27). which have been associated with adhesion and shape change (24,25) and ECM accumulation (27) as well as fibrinolytic processes (26). This study provides the first evidence of an additional role for PAI-1 involving cell migration during early stages in remodeling in glomeruar disease. Cell migration has been proposed to involve a dynamic process involv-ing temporal changes in cell surface plasmin activity and location, allowing loss and subsequent reformation of cell contacts (24,25,27) . The process requires the cyclic appearance of tPA or uPA. PAM, and uPAR at the cell surface, which regulates localized proteolysis and adhesion that in turn governs cell movement (9). Moreover, cell surface plasmin, in contrast to fluid phase plasmin, is protected from a2-anti-plasmin and a2-macroglobulin (43) . supporting a role for the plasminogenlplasmin pathway in a localized environment involving cell adhesion and migration.
. Quantitation of cellular expression of PAI-1 mRNA in glomealar lesions by in situ hybriYizationa
We have previously shown that mesangial cells migrate in vitro in response to platelet releasate and specifically towards gradients of PDGF AB and platelet fibronectin (29.30). and have provided evidence that mesangial cells migrate in vivo during repopulation and remodeling in a platelet-dependent model of proliferative glomerulonephritis induced by HSV (31) . The in vivo studies quantitatively identified the temporal and spatial emergence of mesangial cells at the margins of intact glomerular capillary tuft-lesion interfaces towards the central aspects of glomerular lesions. This margination occurred before proliferation and could be blocked by prior platelet depletion, suggesting that mesangial cells can migrate in vivo towards a milieu of platelet secretory products.
Ir! this study we observed the progressive expression of PAL1 by mesangial cells in this same highly localized pattern associated with mesangial cells at the margins of early lesions. Expression of PAI-1 was highest in mesangial cells at the margins of lesions at sites where the cells are believed be actively involved in migration into glomerular lesions. This investigation is in agreement with other studies in which PAS, PAR, andlor PAI-I have been associated with cells actively involved in motility, such as in trophoblast invasion during implantation (18,44,45) , cells in the parietal and visceral endoderm and mesoderm in remodeling embryonic tissue (44,  46,47) , from the tips of migrating growth cones of regenerating mouse sensory neurons (48,49) , keratinocyte migration in response to wound healing (20,50), macrophage infiltration in inflammation and vascular disease (51,52), and tumor cell invasion (8). In our study, mesangial cells similarly expressed PAI-1 within glomerular lesions at a time during the course of the disease process associated with cell movement. The paradoxical expression of an inhibitor of proteolysis at a time ofcell migration is unclear. However, maximal expression of PAI-1 was observed at 24 hr after HSV, when mesangial cells were already present at the margins of lesions. Therefore, expression of PAL1 in these locations might represent inhibition of proteolysis, stabilization of cell attachments to matrix, and cessation of cell migration. Similar observations have been made in angiogenesis in vitro, in which endothelial cells express PAI-1 during cord development (21). The selective expression of PAL1 in cord development was consistent with active remodeling and was suggested to reflect a graded reduction of the angiogenic response (21).
Macrophages present in the central aspects of glomerular lesions typically did not express PAL1 mRNA or protein, unlike descriptions for macrophages in atheromatous plaques (51). The reason for this is not known but may be related to differences in antibody or probe specificity. Macrophages are generally known to synthesize PAI-2, which has limited overlap in homology with PAL1 (6-8).
These studies do not unequivocally relate PAI-1 expression to cell migration. The lesions associated with HSV involve development of microaneurysms and activation of the coagulation system, including thrombus formation. PAI-1 has been associated with an inhibition offibrinolysis (41); therefore, PAL1 expression by mesangial cells might also be related to regulation of localized fibrin tumover. Our immunofluorescence studies indicate that PAL1 protein co-localized in the immediate vicinity of mesangial cells and might represent an ECM-PAL1 association described for both localized fibrinolysis and at sites of cell migration. Whether PAL1 is operative in one or both mechanisms (cell migration and limitation of fibrinolysis) during the course of HSV-induced glomerular remodeling remains to be determined.
An unexpected result in this study was the observation that mesangial cell expression of PAL1 mRNA and protein diminished by 48 and 72 hr after HSV, at a time when mesangial cells are the predominant cell type in micronodules and ECM synthesis (Fn) was determined to be maximal (this study; and 33). These observations are in contrast to the known association of PAL1 expression and matrix accumulation in a variety of models of fibrosis, including mesangial cell matrix expansion in Thy-1-induced glomerulonephritis (23), and suggest that other regulators, such as inhibitors of metalloproteinases, might be more active than PAI-1 in matrix accumulation in this model. PAL1 was not entirely absent from advanced lesions, however, and the elevated expression in mesangial cells at the margins of lesions at 8 and 24 hr after HSV might reflect a relative metabolic difference in cell activity (migration vs matrix accumulation) at these sites. Of interest are the observations of Hagege et al. (27) indicating that expression of PA14 by mesangial cells in culture was highest during spreading, diminishing as the cells reached confluence. These observations parallel our in vivo results showing highest expression in marginating cells diminishing as the cells form a confluent mass in micronodules, 72 hr after HSV, further suggesting that this inhibitor is important in regulating mesangial cell migration. On the other hand, expression of PAI-1 mRNA and protein progressively increased in epithelial cells lining Bowman's capsule, corresponding to an increase in fibronectin (ECM) synthesis by these cells (this study; and 33). These observations are also consistent with an abundant epithelial cell expression of PA14 relative to mesangial cell expression in murine lupus nephritis (53,54), a renal disease associated with ECM accumulation.
We can only speculate on the factors that stimulate mesangial cell expression of PAI-1 synthesis during the course of HSV-induced glomerular injury. A variety of biologically active proteins, including TGF-P, PDGF, thrombin, and others are known to stimulate synthesis of PAL1 in a variety of cell types (4,7). Platelets contain many of these same factors ( 5 5 ) and are present within glomerular lesions throughout the course of HSV-induced glomerulonephritis
The clinical significance of cell migration in glomerular lesions has not been defined. Cell migration might be an early event during tissue remodeling, preceding proliferation and ECM accumulation during the natural history of glomerular disease. This is of particular interest when one considers the observations that a variety of glomerular diseases (including IgA nephropathy, Henoch-Schonlein purpura, diabetic nephropathy, and lupus nephritis) have episodes of mesangiolysis in common during the disease process (56-60). In addition, mesangial cell migration has been proposed as an early event in membranoproliferative glomerulonephritis (28,30). Therefore, remodeling in glomerular disease might involve cell migration and activation of the plasmhogen activator system as an early step in repopulation of glomerular lesions. Understanding the cellular mechanisms involving early alterations in cell adhesion to ECM and cell motility in tissue remodeling after glomerular injury will provide further insight into future therapeutic regimens to treat progressive glomerular disease. 
